Pharmaceutical firm pivots to stablecoins, holds nearly 9% of SKY's supply

A pharmaceutical firm has shifted its focus to stablecoins, now holding nearly 9% of the total supply of the cryptocurrency SKY. This strategic pivot aims to leverage the stability of stablecoins in the volatile crypto market. The firm believes that integrating digital assets can enhance its financial operations and investment strategies. This move reflects a growing trend among traditional companies exploring opportunities within the cryptocurrency space.

Read the full article: CoinDesk

Read more